Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Behbahani Ali
Relationship:   Director
City:   Timonium
State:   MD
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   66,478    

Indirect Shares

   101,863,965      
Direct Value   $421,575    

Indirect Value

   $381,265,459      
Total Shares   101,930,443      
Total Value   $381,687,035      


Nevro Corp $56,649 Crispr Therapeutics Ag $13,709 Black Diamond Therapeutics, Inc. $348,908 Minerva Surgical Inc $0 Arcellx, Inc. $0 Cvrx, Inc. $2,310 Nevro Corp $56,649 Crispr Therapeutics Ag $13,709 Black Diamond Therapeutics, Inc. $348,908 Minerva Surgical Inc $0 Arcellx, Inc. $0 Cvrx, Inc. $2,310
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    6   
    0    

     Stock price went up :
    3   
    0    
     Stock price went down :
    3   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   8.3%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nevro Corp NVRO Director 2018-05-21 5,390 2015-12-02 0    Premium*  
            Crispr Therapeutics Ag CRSP Director 2020-08-13 256 2020-08-13 14    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director 2018-09-07 0 2020-01-24 19,500,000    Premium*  
            Genocea Biosciences, Inc. GNCA Director, 10% Owner 2019-02-14 0 2022-05-25 0    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 2019-05-07 0 2020-12-04 6,451,056    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2022-04-11 948,948    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2023-06-13 135    Premium*  
            Black Diamond Therapeutics, Inc. BDTX 2024-03-15 51,690 2024-03-15 4,448,757    Premium*  
            Oyster Point Pharma, Inc. OYST Director 2023-01-03 0 2020-06-08 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 0 2022-11-30 0    Premium*  
            Metacrine, Inc. MTCR 10% Owner 2020-09-18 0 2021-12-22 2,563,257    Premium*  
            Savara Inc SVRA 10% Owner 0 2023-07-17 24,471,264    Premium*  
            Marker Therapeutics Inc MRKR 10% Owner 2021-03-16 0 2021-03-16 10,714,285    Premium*  
            Monte Rosa Therapeutics, Inc. GLUE Director, 10% Owner 2021-06-28 0 2021-06-28 7,692,298    Premium*  
            Bright Health Group Inc. BHG 10% Owner 2021-06-28 0 2021-06-28 23,983,073    Premium*  
            Minerva Surgical Inc UTRS Director 2021-10-26 8,487 2021-10-26 0    Premium*  
            Arcellx, Inc. ACLX Director 2023-06-01 339 2023-06-01 85    Premium*  
            Korro Bio KRRO 2023-11-03 0 2024-04-22 1,090,793    Premium*  
            Cvrx, Inc. CVRX Director 2023-12-14 316 2023-12-14 0    Premium*  
* Premium Members only  

Records found :    69         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NVRO Nevro Corp Director   –       •      –    2015-12-02 4 A $0.00 $0 D/D 25 25 0 -
NVRO Nevro Corp Director   –       •      –    2016-11-11 4 A $0.00 $0 D/D 22 47 0 -
NVRO Nevro Corp Director   –       •      –    2017-05-25 4 A $0.00 $0 D/D 1,518 1,565 0 -
NVRO Nevro Corp Director   –       •      –    2017-09-14 4 A $0.00 $0 D/D 40 1,605 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2018-05-14 4 A $0.00 $0 D/D 199 199 0 -
NVRO Nevro Corp Director   –       •      –    2018-05-21 4 A $0.00 $0 D/D 3,785 5,390 0 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2018-09-07 4 B $1.67 $20,000,400 I/I 12,000,000 12,000,000 2.1 -
GNCA Genocea Biosciences, Inc. Director   –       •       •   2019-02-14 4 B $0.47 $4,688,619 I/I 9,948,269 34,948,269 2.25 -
RGLS Regulus Therapeutics Inc. 10% Owner   –       –       •   2019-05-07 4 B $1.08 $1,227,640 I/I 1,136,704 2,052,454 1.5 -
TRVI Trevi Therapeutics, Inc. 10% Owner   –       –       •   2019-05-09 4 B $10.00 $25,000,000 I/I 2,500,000 4,438,562 1.5 -
TRVI Trevi Therapeutics, Inc. 10% Owner   –       –       •   2019-05-09 4 A $0.00 $0 I/I 1,938,562 1,938,562 0 -
GNCA Genocea Biosciences, Inc. Director   –       •       •   2019-06-24 4 B $3.50 $9,999,997 I/I 2,857,142 7,225,676 2.25 -
MIRM Mirum Pharmaceuticals, In... 10% Owner   –       –       •   2019-07-22 4 A $0.00 $0 I/I 3,736,243 3,736,243 0 -
MIRM Mirum Pharmaceuticals, In... 10% Owner   –       –       •   2019-07-22 4 B $15.00 $6,750,000 I/I 450,000 4,186,243 1.5 -
ADAP Adaptimmune Therapeutics ... Director   –       •      –    2020-01-24 4 B $0.67 $5,000,250 I/I 7,500,000 19,500,000 2.1 %
BDTX Black Diamond Therapeutic... Director   –       •      –    2020-02-03 4 A $0.00 $0 I/I 2,648,757 2,648,757 0 -
BDTX Black Diamond Therapeutic... Director   –       •      –    2020-02-03 4 B $19.00 $15,200,000 I/I 800,000 3,448,757 2.1 %
TRVI Trevi Therapeutics, Inc. 10% Owner   –       –       •   2020-04-03 4 S $2.66 $1,500 I/I (564) 5,937,998 0 -
TRVI Trevi Therapeutics, Inc. 10% Owner   –       –       •   2020-04-03 4 OE $0.00 $1,500 I/I 1,500,000 5,938,562 0 -
OYST Oyster Point Pharma, Inc. Director   –       •      –    2020-06-08 4 A $0.00 $0 D/D 6,600 6,600 0 -
AKUS Akouos, Inc. 10% Owner   –       –       •   2020-06-30 4 A $0.00 $0 I/I 3,705,972 3,705,972 0 -
AKUS Akouos, Inc. 10% Owner   –       –       •   2020-06-30 4 B $17.00 $9,999,995 I/I 588,235 4,294,207 1.5 -
GNCA Genocea Biosciences, Inc. Director   –       •       •   2020-07-24 4 B $2.25 $7,090,335 I/I 3,151,260 10,376,936 2.25 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2020-08-13 4 A $0.00 $0 D/D 57 256 0 -
CRSP Crispr Therapeutics Ag Director   –       •      –    2020-08-13 4 A $0.00 $0 I/I 14 14 0 -
  69  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us